Latest News
Latest News and Events
- All
- Events
- Featured
- Imspex Clinical
- Imspex Industrial
Imspex to Present at BioSeed 2025
Imspex at Arab Health 2025
Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab
David Wilson Joins Imspex as Non-Executive Director
IMSPEX NEWS
Meet Robin Curnow
Meet Trenton Stewart
BioWales in London
BioWales in London Pre-Event at The Shard
IMSPEX Achieves New ISO Standard
ONELAB Installation at the Amsterdam University Medical Center
ISO Certification
ONELAB Annual Meeting
ONELAB Installations
Bevan Commission NHS 75 Conference
LSX World Congress 2023
AngloNordic Life Science Conference 2023
MediWales Connects NHS Collaboration Conference 2023
BioWales in London
Arab Health 2023
Group B Streptococcus
Urine analysis for disease diagnostics or rapid screening
TOXI- Triage
TOXI – Triage – DISPERSE exercise
Leicester publication highlights Imspex and GC-IMS
MediWales Innovation Awards 2022
ONELAB
Everyday household items that contain VOCs
GC-IMS highlights Imspex as Benchmark Technology in VOC Gas
Bond Digital Health Partners with Imspex Group
What’s your FlavourSpec this Oktoberfest?
Co-Vid 19 Resilience Innovation success
Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer
BBC exposure for BreathSpec system
Monitoring of Toxic Industrial Chemicals (TICs)
Siloxanes in biogas gas from landfill waste
Authenticity of extra virgin olive oil
Imspex Diagnostics Awarded SMART FIS Grant
Imspex to Present at BioSeed 2025
We’re pleased to share that Imspex Diagnostics will be represented at BioSeed 2025, taking place on 9 June in London. Hosted by OBN, BioSeed is
Imspex at Arab Health 2025
Imspex Diagnostics is proud to announce our participation at Arab Health 2025, one of the world’s largest healthcare exhibitions, taking place from 27th to 30th
Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab
We are pleased to announce a significant collaboration between Imspex Diagnostics Ltd and Biophys Limited, aimed at advancing SMART diagnostics and R&D services. This partnership
David Wilson Joins Imspex as Non-Executive Director
Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years
IMSPEX NEWS
PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics.
Meet Robin Curnow
📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful
Meet Trenton Stewart
IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and
BioWales in London
Tuesday 5th March, Canary Wharf, London IMSPEX is excited to share that our Group CEO, John McKinley, will be delivering a presentation at the MediWales
BioWales in London Pre-Event at The Shard
We’re pleased to announce that our Group CEO John McKinley will be participating in a panel discussion at Mathys & Squire IP Firm, located at The Shard
IMSPEX Achieves New ISO Standard
We are pleased to announce that Imspex Diagnostic Ltd has achieved a significant milestone: the publication of a new ISO standard for Siloxane testing. Developed
ONELAB Installation at the Amsterdam University Medical Center
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Amsterdam University Medical Center. This achievement is part of the ONELAB project,
ISO Certification
Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement
ONELAB Annual Meeting
IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the
ONELAB Installations
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the
Bevan Commission NHS 75 Conference
5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting
LSX World Congress 2023
3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part
AngloNordic Life Science Conference 2023
Our Group CEO John McKinley and PR, Social Media and Marketing Manager Amber Jacobs will be attending the 19th Annual AngloNordic Life Science Conference 2023
MediWales Connects NHS Collaboration Conference 2023
29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with
BioWales in London
Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March
Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th
Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is
Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic
TOXI- Triage
In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency
TOXI – Triage – DISPERSE exercise
On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a
Leicester publication highlights Imspex and GC-IMS
Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and
MediWales Innovation Awards 2022
Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about
ONELAB
Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and
Everyday household items that contain VOCs
VOCs are compounds that easily become gases or vapours and are made up of lots of different elements where one of the elements is carbon.
GC-IMS highlights Imspex as Benchmark Technology in VOC Gas
We are very proud to have been highlighted by the ISO committe as the benchmark in VOC Gas technology.
Bond Digital Health Partners with Imspex Group
Bond Digital Health and Imspex Diagnostics will be working together on an exciting new technology.
What’s your FlavourSpec this Oktoberfest?
For brewers, having access to an instrument such as FlavourSpec could be business transformational.
Co-Vid 19 Resilience Innovation success
Imspex Diagnostics was successful in its recent SMARTCymru application for funding to further establish its BreathSpec® technology’s potential as a channel to boost economic recovery
Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer
Low level detection of Sulphur compounds in Natural gas using the Agilent Micro GC with Ion Mobility Spectrometer. G.A.S mbH re-engineered its sophisticated Ion Mobility
BBC exposure for BreathSpec system
BreathSpec system and the BBC – How should we deal with a chemical attack? The BreathSpec system has been gaining much publicity recently. Read about
Monitoring of Toxic Industrial Chemicals (TICs)
Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects
Siloxanes in biogas gas from landfill waste
The generation of electricity from land fill is of increasing interest as a form of renewable energy to be used on site or sold to
Authenticity of extra virgin olive oil
Want to know about how authentic extra virgin olive oil is? Keep reading… Extra virgin olive oil has always been a popular oil used in
Imspex Diagnostics Awarded SMART FIS Grant
Abercynon, Wales – November 28th, 2024. Imspex Diagnostics is pleased to announce its successful application for a SMART Flexible Innovation Support (SMART FIS) grant, awarded